This classified ad has expiredClick here to view current advertisements similar to this one.
Emerging Medical Investment DestinationsIf you are looking for new investments for your projects this year, it is a great time to find prospects in international markets.ChinaDo Chinese investors offer investments in the biotechnology & healthcare sectors? Chinese investors are now seeking to grow in international markets, this is achieved both by investing in innovations and through acquisitions. Increasing number of Chinese investment firms are being set up by those professionals returned from North America and Europe; and they have brought in a lot of experience in terms of corporate advisory and structuring the deals in international standards. Chinese VCs have also worked with many international VCs and establish large size private equity firms able to take on very large deals globally. They now have abilities to invest in $100m even $500m deals.2011 will also be the beginning of a year where Chinese Private Equity firms will start funding Chinese medical companies to make acquisitions in global opportunities.Examples: BioVeda China Ltd, Canton Venture Capital Co. Ltd, China Science & Merchants Venture Capital ManagementSingaporeAnother emerging investment destination from Asia is Singapore. Singapore, under the guidance from its Government has been investing in international markets since the early 1980s; and biotechnology & healthcare sectors are no exceptions. Companies such as Temasek which is Government sponsored investment firm are some of the world’s most active private equity investors; additionally, Singaporean investment firms are also encouraging companies to establish their R&D facilities in Singapore.Examples: Bio*One Capital Pte Ltd, DBS Private Equity, TemasekAustraliaAlthough a small venture capital market in global standard; and lack of the Government led initiatives as those in Singapore, Hong Kong or Middle East; Australia has been a breeding ground for very successful biotechnology companies and this has also assisted the nation to be one of the most active investors in terms of healthcare sectors in the region. Some of the successful funds were led by successful directors from Australia’s largest biotechnology / pharmaceutical companies such as CSL Ltd, Cochlear, iSoft, Biota Holdings, ResMed. Examples: Uniseed Management Pty Ltd, Titan BioVentures ManagementCanadaCanada is another market worth consideration, in addition to pharmaceuticals, it is also a leader in medical devices; e-health; it also has very strong research capability.Canadian firms have invested both early stage pharmaceutical companies to late stage, large size deals; Toronto Stock Exchange (TSX) is also a popular stock exchange for medical companies for listing. Canadian companies also have a specific geographical and economic advantage being close to the major US market, especially the financial services market; with opportunities to work with both Canadian & US based institutions and R&D organizations.Examples: Canadian Medical Discoveries Fund Inc; CentreStone Ventures; Desjardins Venture CapitalGlobal Biotechnology Capital Providers Guide:This is an essential database if you are looking for investors for your medical / healthcare related projects.For more information about Global Biotechnology Capital Providers Guide, please visit our website [please contact me for website address]